nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—Tooth abscess—Metformin—polycystic ovary syndrome	0.0224	0.0459	CcSEcCtD
Fentanyl—Acidosis—Metformin—polycystic ovary syndrome	0.0169	0.0346	CcSEcCtD
Fentanyl—Respiratory distress—Metformin—polycystic ovary syndrome	0.0147	0.0302	CcSEcCtD
Fentanyl—Upset stomach—Metformin—polycystic ovary syndrome	0.0143	0.0292	CcSEcCtD
Fentanyl—Fungal infection—Metformin—polycystic ovary syndrome	0.0121	0.0248	CcSEcCtD
Fentanyl—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0115	0.0237	CcSEcCtD
Fentanyl—Rigors—Metformin—polycystic ovary syndrome	0.0114	0.0235	CcSEcCtD
Fentanyl—Contusion—Metformin—polycystic ovary syndrome	0.0107	0.022	CcSEcCtD
Fentanyl—Chest discomfort—Metformin—polycystic ovary syndrome	0.0106	0.0217	CcSEcCtD
Fentanyl—Accidental injury—Metformin—polycystic ovary syndrome	0.0106	0.0217	CcSEcCtD
Fentanyl—Neuropathy—Metformin—polycystic ovary syndrome	0.00877	0.018	CcSEcCtD
Fentanyl—Ear pain—Metformin—polycystic ovary syndrome	0.00795	0.0163	CcSEcCtD
Fentanyl—Nasal congestion—Metformin—polycystic ovary syndrome	0.00744	0.0153	CcSEcCtD
Fentanyl—Injury—Metformin—polycystic ovary syndrome	0.00738	0.0151	CcSEcCtD
Fentanyl—Renal impairment—Metformin—polycystic ovary syndrome	0.00713	0.0146	CcSEcCtD
Fentanyl—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00695	0.0143	CcSEcCtD
Fentanyl—Lethargy—Metformin—polycystic ovary syndrome	0.00692	0.0142	CcSEcCtD
Fentanyl—Pain in extremity—Metformin—polycystic ovary syndrome	0.00678	0.0139	CcSEcCtD
Fentanyl—Dehydration—Metformin—polycystic ovary syndrome	0.00631	0.0129	CcSEcCtD
Fentanyl—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00619	0.0127	CcSEcCtD
Fentanyl—Breast disorder—Metformin—polycystic ovary syndrome	0.00613	0.0126	CcSEcCtD
Fentanyl—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00606	0.0124	CcSEcCtD
Fentanyl—Abdominal distension—Metformin—polycystic ovary syndrome	0.0059	0.0121	CcSEcCtD
Fentanyl—Influenza—Metformin—polycystic ovary syndrome	0.00586	0.012	CcSEcCtD
Fentanyl—Angina pectoris—Metformin—polycystic ovary syndrome	0.00571	0.0117	CcSEcCtD
Fentanyl—Sweating increased—Metformin—polycystic ovary syndrome	0.00571	0.0117	CcSEcCtD
Fentanyl—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00562	0.0115	CcSEcCtD
Fentanyl—Neutropenia—Metformin—polycystic ovary syndrome	0.00548	0.0112	CcSEcCtD
Fentanyl—Loperamide—POMC—polycystic ovary syndrome	0.00545	0.164	CrCbGaD
Fentanyl—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00545	0.0112	CcSEcCtD
Fentanyl—Infestation NOS—Metformin—polycystic ovary syndrome	0.00523	0.0107	CcSEcCtD
Fentanyl—Infestation—Metformin—polycystic ovary syndrome	0.00523	0.0107	CcSEcCtD
Fentanyl—Drowsiness—Metformin—polycystic ovary syndrome	0.00523	0.0107	CcSEcCtD
Fentanyl—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00512	0.0105	CcSEcCtD
Fentanyl—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00494	0.0101	CcSEcCtD
Fentanyl—Bradycardia—Metformin—polycystic ovary syndrome	0.00478	0.0098	CcSEcCtD
Fentanyl—Rhinitis—Metformin—polycystic ovary syndrome	0.0047	0.00965	CcSEcCtD
Fentanyl—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00467	0.00958	CcSEcCtD
Fentanyl—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00462	0.00948	CcSEcCtD
Fentanyl—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00461	0.00946	CcSEcCtD
Fentanyl—Eye disorder—Metformin—polycystic ovary syndrome	0.00438	0.00899	CcSEcCtD
Fentanyl—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00435	0.00893	CcSEcCtD
Fentanyl—Flushing—Metformin—polycystic ovary syndrome	0.00435	0.00893	CcSEcCtD
Fentanyl—Angiopathy—Metformin—polycystic ovary syndrome	0.00426	0.00873	CcSEcCtD
Fentanyl—Immune system disorder—Metformin—polycystic ovary syndrome	0.00424	0.00869	CcSEcCtD
Fentanyl—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00423	0.00867	CcSEcCtD
Fentanyl—Chills—Metformin—polycystic ovary syndrome	0.00421	0.00864	CcSEcCtD
Fentanyl—Malnutrition—Metformin—polycystic ovary syndrome	0.00408	0.00838	CcSEcCtD
Fentanyl—Erythema—Metformin—polycystic ovary syndrome	0.00408	0.00838	CcSEcCtD
Fentanyl—Flatulence—Metformin—polycystic ovary syndrome	0.00402	0.00826	CcSEcCtD
Fentanyl—Dysgeusia—Metformin—polycystic ovary syndrome	0.004	0.0082	CcSEcCtD
Fentanyl—Muscle spasms—Metformin—polycystic ovary syndrome	0.00393	0.00806	CcSEcCtD
Fentanyl—Vision blurred—Metformin—polycystic ovary syndrome	0.00385	0.0079	CcSEcCtD
Fentanyl—Tremor—Metformin—polycystic ovary syndrome	0.00383	0.00785	CcSEcCtD
Fentanyl—Benazepril—MTHFR—polycystic ovary syndrome	0.00381	0.115	CrCbGaD
Fentanyl—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00379	0.00777	CcSEcCtD
Fentanyl—Modafinil—ADRA1B—polycystic ovary syndrome	0.00378	0.114	CrCbGaD
Fentanyl—Malaise—Metformin—polycystic ovary syndrome	0.00368	0.00756	CcSEcCtD
Fentanyl—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.00367	0.11	CrCbGaD
Fentanyl—Syncope—Metformin—polycystic ovary syndrome	0.00366	0.00751	CcSEcCtD
Fentanyl—Palpitations—Metformin—polycystic ovary syndrome	0.00361	0.0074	CcSEcCtD
Fentanyl—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00359	0.00736	CcSEcCtD
Fentanyl—Quinapril—ACE—polycystic ovary syndrome	0.00357	0.107	CrCbGaD
Fentanyl—Hypertension—Metformin—polycystic ovary syndrome	0.00353	0.00723	CcSEcCtD
Fentanyl—Chest pain—Metformin—polycystic ovary syndrome	0.00348	0.00713	CcSEcCtD
Fentanyl—Myalgia—Metformin—polycystic ovary syndrome	0.00348	0.00713	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00345	0.00708	CcSEcCtD
Fentanyl—Discomfort—Metformin—polycystic ovary syndrome	0.00344	0.00705	CcSEcCtD
Fentanyl—Oedema—Metformin—polycystic ovary syndrome	0.00333	0.00684	CcSEcCtD
Fentanyl—Infection—Metformin—polycystic ovary syndrome	0.00331	0.00679	CcSEcCtD
Fentanyl—Shock—Metformin—polycystic ovary syndrome	0.00328	0.00673	CcSEcCtD
Fentanyl—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00327	0.00671	CcSEcCtD
Fentanyl—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00326	0.00669	CcSEcCtD
Fentanyl—Skin disorder—Metformin—polycystic ovary syndrome	0.00324	0.00664	CcSEcCtD
Fentanyl—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00322	0.00661	CcSEcCtD
Fentanyl—Anorexia—Metformin—polycystic ovary syndrome	0.00318	0.00652	CcSEcCtD
Fentanyl—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.00313	0.0941	CrCbGaD
Fentanyl—Hypotension—Metformin—polycystic ovary syndrome	0.00311	0.00639	CcSEcCtD
Fentanyl—Benazepril—ACE—polycystic ovary syndrome	0.0031	0.0934	CrCbGaD
Fentanyl—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00304	0.00623	CcSEcCtD
Fentanyl—Paraesthesia—Metformin—polycystic ovary syndrome	0.00299	0.00614	CcSEcCtD
Fentanyl—Dyspnoea—Metformin—polycystic ovary syndrome	0.00297	0.0061	CcSEcCtD
Fentanyl—Somnolence—Metformin—polycystic ovary syndrome	0.00296	0.00608	CcSEcCtD
Fentanyl—Dyspepsia—Metformin—polycystic ovary syndrome	0.00293	0.00602	CcSEcCtD
Fentanyl—Decreased appetite—Metformin—polycystic ovary syndrome	0.0029	0.00594	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00288	0.0059	CcSEcCtD
Fentanyl—Fatigue—Metformin—polycystic ovary syndrome	0.00287	0.0059	CcSEcCtD
Fentanyl—Constipation—Metformin—polycystic ovary syndrome	0.00285	0.00585	CcSEcCtD
Fentanyl—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00275	0.00563	CcSEcCtD
Fentanyl—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00273	0.00559	CcSEcCtD
Fentanyl—Urticaria—Metformin—polycystic ovary syndrome	0.00265	0.00543	CcSEcCtD
Fentanyl—Abdominal pain—Metformin—polycystic ovary syndrome	0.00264	0.00541	CcSEcCtD
Fentanyl—Asthenia—Metformin—polycystic ovary syndrome	0.00239	0.00491	CcSEcCtD
Fentanyl—Pruritus—Metformin—polycystic ovary syndrome	0.00236	0.00484	CcSEcCtD
Fentanyl—Diarrhoea—Metformin—polycystic ovary syndrome	0.00228	0.00468	CcSEcCtD
Fentanyl—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.0022	0.0663	CrCbGaD
Fentanyl—Dizziness—Metformin—polycystic ovary syndrome	0.0022	0.00452	CcSEcCtD
Fentanyl—Vomiting—Metformin—polycystic ovary syndrome	0.00212	0.00435	CcSEcCtD
Fentanyl—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00211	0.0634	CrCbGaD
Fentanyl—Rash—Metformin—polycystic ovary syndrome	0.0021	0.00431	CcSEcCtD
Fentanyl—Dermatitis—Metformin—polycystic ovary syndrome	0.0021	0.00431	CcSEcCtD
Fentanyl—Headache—Metformin—polycystic ovary syndrome	0.00209	0.00428	CcSEcCtD
Fentanyl—Nausea—Metformin—polycystic ovary syndrome	0.00198	0.00406	CcSEcCtD
Fentanyl—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.00125	0.0377	CrCbGaD
Fentanyl—Methadone—CYP19A1—polycystic ovary syndrome	0.00118	0.0355	CrCbGaD
Fentanyl—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000258	0.000539	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000256	0.000533	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.000252	0.000525	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000251	0.000523	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000251	0.000523	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00025	0.000523	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00025	0.000522	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000249	0.000519	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000246	0.000514	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000246	0.000513	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000246	0.000512	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000244	0.000509	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00024	0.000501	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00024	0.000501	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000239	0.000498	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000238	0.000497	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000235	0.00049	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000234	0.000489	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000234	0.000488	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000233	0.000486	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000233	0.000485	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000232	0.000484	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000232	0.000484	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00023	0.00048	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000228	0.000475	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000227	0.000474	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000225	0.000469	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000224	0.000468	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.00022	0.000459	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00022	0.000458	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000218	0.000455	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000216	0.00045	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000215	0.000448	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000214	0.000447	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000214	0.000446	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000213	0.000444	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000212	0.000441	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000211	0.00044	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00021	0.000438	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000209	0.000436	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000209	0.000435	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000208	0.000433	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000206	0.000429	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000204	0.000426	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000203	0.000423	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000202	0.000422	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000201	0.000419	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.0002	0.000417	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000199	0.000415	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000199	0.000415	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000198	0.000414	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000198	0.000414	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000197	0.000411	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000197	0.00041	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000196	0.000409	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000195	0.000406	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000192	0.000401	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000192	0.000401	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000189	0.000395	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000188	0.000393	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000186	0.000388	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000186	0.000387	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000185	0.000386	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000185	0.000386	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000182	0.000381	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000181	0.000377	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.00018	0.000376	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000179	0.000374	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000179	0.000374	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000178	0.000372	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000178	0.000372	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000177	0.00037	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000177	0.000369	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000176	0.000368	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000176	0.000368	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000174	0.000364	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000174	0.000362	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000172	0.000359	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000171	0.000357	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000169	0.000353	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000169	0.000352	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000169	0.000352	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	0.000167	0.000348	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000167	0.000348	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000166	0.000347	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000165	0.000344	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000164	0.000343	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000163	0.00034	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000162	0.000338	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000162	0.000338	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000162	0.000338	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000161	0.000337	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000159	0.000332	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000157	0.000329	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000156	0.000326	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000156	0.000325	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000156	0.000325	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000155	0.000323	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000155	0.000322	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000155	0.000322	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000154	0.000322	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000153	0.00032	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000153	0.000319	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000151	0.000316	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000151	0.000315	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000151	0.000315	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.00015	0.000313	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00015	0.000313	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00015	0.000313	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000149	0.000311	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000147	0.000308	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000146	0.000305	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000144	0.0003	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000143	0.000299	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000143	0.000298	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000142	0.000296	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000142	0.000296	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000142	0.000295	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000137	0.000286	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000137	0.000286	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000136	0.000285	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000135	0.000282	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000134	0.000281	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000134	0.00028	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000134	0.00028	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000134	0.000279	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000133	0.000277	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TH—polycystic ovary syndrome	0.000133	0.000277	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000132	0.000276	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000131	0.000273	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.00013	0.000272	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000129	0.000269	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000128	0.000267	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000128	0.000266	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000127	0.000265	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000126	0.000263	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000126	0.000262	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000124	0.00026	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000122	0.000255	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000122	0.000255	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000121	0.000253	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000121	0.000252	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000121	0.000252	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00012	0.00025	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00012	0.00025	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000119	0.000249	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000119	0.000247	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000116	0.000243	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000116	0.000243	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000115	0.000241	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000114	0.000238	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000114	0.000237	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000113	0.000237	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000113	0.000235	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000111	0.000232	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000111	0.000231	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00011	0.00023	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	0.000108	0.000226	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000105	0.00022	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	0.000103	0.000215	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000102	0.000214	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000101	0.000212	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.0001	0.000209	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.97e-05	0.000208	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.93e-05	0.000207	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.84e-05	0.000205	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	9.83e-05	0.000205	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	9.77e-05	0.000204	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	9.76e-05	0.000204	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.7e-05	0.000202	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TH—polycystic ovary syndrome	9.58e-05	0.0002	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	9.56e-05	0.000199	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	9.51e-05	0.000198	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	9.47e-05	0.000198	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	9.32e-05	0.000195	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.26e-05	0.000193	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.2e-05	0.000192	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.19e-05	0.000192	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	9.11e-05	0.00019	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	9.1e-05	0.00019	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	8.99e-05	0.000188	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	8.76e-05	0.000183	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.73e-05	0.000182	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.71e-05	0.000182	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	8.49e-05	0.000177	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.43e-05	0.000176	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	8.38e-05	0.000175	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	8.36e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	8.34e-05	0.000174	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.25e-05	0.000172	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	8.25e-05	0.000172	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.06e-05	0.000168	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.06e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.87e-05	0.000164	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	7.82e-05	0.000163	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.66e-05	0.00016	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	7.45e-05	0.000155	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	7.39e-05	0.000154	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.36e-05	0.000154	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	7.29e-05	0.000152	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INS—polycystic ovary syndrome	7.25e-05	0.000151	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.23e-05	0.000151	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.18e-05	0.00015	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	7.08e-05	0.000148	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	7.06e-05	0.000147	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	7.05e-05	0.000147	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.03e-05	0.000147	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.03e-05	0.000147	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.02e-05	0.000146	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.81e-05	0.000142	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.81e-05	0.000142	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.79e-05	0.000142	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	6.61e-05	0.000138	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	6.59e-05	0.000137	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.47e-05	0.000135	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.25e-05	0.00013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.17e-05	0.000129	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.06e-05	0.000126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.01e-05	0.000125	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	5.9e-05	0.000123	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.84e-05	0.000122	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.62e-05	0.000117	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.61e-05	0.000117	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.54e-05	0.000116	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	5.34e-05	0.000111	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.33e-05	0.000111	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	5.27e-05	0.00011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.27e-05	0.00011	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INS—polycystic ovary syndrome	5.24e-05	0.000109	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.23e-05	0.000109	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.21e-05	0.000109	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.15e-05	0.000107	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.97e-05	0.000104	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.46e-05	9.3e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.45e-05	9.29e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.33e-05	9.04e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	4.15e-05	8.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.07e-05	8.5e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.03e-05	8.41e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.97e-05	8.29e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.95e-05	8.25e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	3.64e-05	7.6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.64e-05	7.59e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.46e-05	7.23e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.28e-05	6.85e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.08e-05	6.42e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.06e-05	6.39e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.48e-05	5.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.45e-05	5.11e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.44e-05	5.08e-05	CbGpPWpGaD
